Clinical Applications: Veterinary

Anticoagulant Testing in Pets

A number of conditions can require that pets – in particular, dogs and cats – be tested for blot clotting capability. These situations can include accidental ingestion of rodent poisons, which use anti-coagulants. Thousands of cases of pet poisoning by rodent bait are reported each year. Additionally, cardiomyopathy in cats can require testing when anti-coagulants are used therapeutically. Chronic liver disease and sulfa-type antibiotics have also been known to increase blood clotting time and may require pet testing.

Using a point-of-care test such as Micropoint’s qLabs® Vet Coag Panel 2 (PTT/aPTT combined test) enables vets to avoid the involved and lengthy process of sending samples out to a lab for analysis. Using the qLabs hand held device vets can obtain results in 7 minutes, reducing lab costs and staff time.  

 

 

U.S. Headquarters

 

Micropoint Bioscience, Inc.
3521 Leonard Court 
Santa Clara, CA 95054
United States

 

T:+1 (408) 588-1682
F:+1 (408) 588-1620

 

 

European Office

 

Micropoint Bioscience, Inc.

2 rue Eugene Sue

38100 Grenoble

France 

 

T: +33 6 22 38 20 48

F: +33 4 76 09 03 50

Asian Office

 

Micropoint Biotechnologies Co., Ltd.

5F, Bldg 1

Runheng Dingfeng Industrial Park, Liuxian 2 Rd.

Shenzhen 518101, Guangdong

China

 

T: +86 755 21600849

F: +86 755 86673903

Copyright Micropoint Biosciences 2016

Micropoint Bioscience products are not available for sale nor marketed in the United States at this time.